Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori

Abstract

The quadruple regimens with or without bismuth achieved moderate eradication rates as a first-line eradication option of Helicobacter pylori in our population, in which a bismuth-based regimen seems more appropriate. The compliance and side effects are important issues affecting the success of these regimens.